KREKENAVOS VAISTINĖ - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 124,521 | 144,704 | 178,595 | 160,158 | 195,814 | 195,772 | 212,683 | 216,355 |
| Profit before tax | 1,611 | 2,938 | 4,878 | 935 | 1,354 | 148 | 77 | -2,851 |
| Net profit | 1,587 | 2,894 | 4,634 | 888 | 1,286 | 141 | 73 | -2,851 |
| Equity | 12,696 | 15,647 | 20,237 | 21,125 | 22,411 | 22,552 | 22,632 | 19,784 |
| Liabilities | 22,756 | 24,026 | 22,732 | 31,632 | 28,019 | 26,625 | 19,405 | 26,443 |
| Non-current assets | 16,403 | 15,792 | 15,807 | 15,004 | 14,202 | 13,400 | 12,789 | 12,688 |
| Current assets | 19,049 | 23,881 | 27,162 | 37,753 | 36,228 | 34,477 | 28,248 | 33,539 |
| Total assets | 35,452 | 39,673 | 42,969 | 52,757 | 50,430 | 47,877 | 41,037 | 46,227 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 2,288 | 2,820 | 3,217 |
| Social insurance contributions | - | - | - | - | - | 6,896 | 7,986 | 8,713 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +4.6% | +16.2% | +23.4% | -10.3% | +22.3% | 0.0% | +8.6% | +1.7% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 4.5% | 7.3% | 10.8% | 1.7% | 2.6% | 0.3% | 0.2% | -6.2% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 12.5% | 18.5% | 22.9% | 4.2% | 5.7% | 0.6% | 0.3% | -14.4% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 1.3% | 2.0% | 2.6% | 0.6% | 0.7% | 0.1% | 0.0% | -1.3% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 1.3% | 2.0% | 2.7% | 0.6% | 0.7% | 0.1% | 0.0% | -1.3% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 1.8 | 1.5 | 1.1 | 1.5 | 1.3 | 1.2 | 0.9 | 1.3 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 20,754 | 24,117 | 29,766 | 26,693 | 32,636 | 32,629 | 35,447 | 36,059 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
KREKENAVOS VAISTINĖ - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2025-11-18 | 2025-12-07 | 2.30 |
| 2025-10-23 | 2025-11-12 | 2.30 |
| 2025-07-16 | 2025-07-23 | 947.22 |
| 2023-12-18 | 2023-12-26 | 1.08 |
| 2023-11-16 | 2023-12-10 | 1.08 |
| 2023-10-25 | 2023-11-05 | 1.08 |
| 2023-09-18 | 2023-09-19 | 747.20 |
| 2023-05-16 | 2023-06-11 | 0.36 |
| 2023-05-02 | 2023-05-07 | 0.36 |
| 2023-04-27 | 2023-04-28 | 0.36 |
| 2023-04-25 | 2023-04-25 | 0.36 |
| 2023-02-17 | 2023-02-20 | 738.61 |
KREKENAVOS VAISTINĖ - VMI tax arrears
The company had no tax arrears (debts) to the State Tax Inspectorate
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
KREKENAVOS VAISTINE, UAB (code 268599220) is a Private Limited Liability Company engaged in the retail sale of pharmaceutical products. In 2025, the company generated revenue of €216.4K, up 1.7% year on year and 10.5% over two years. However, profitability weakened materially: net profit turned to a loss of €2.9K, compared with a profit of €73 in 2024 and €141 in 2023. The 2025 profit margin was -1.3%, reflecting pressure on operating performance after two years of near break-even results. Total assets stood at €46.2K at the end of 2025, compared with €41.0K in 2024 and €47.9K in 2023. Equity declined to €19.8K from €22.6K a year earlier, while liabilities increased to €26.4K from €19.4K. The balance sheet shows an equity ratio of 42.8% and debt-to-equity of 1.34. Asset turnover was 4.68x. Revenue per employee was €36.1K, while profit per employee was -€475, indicating that sales growth in 2025 did not translate into positive earnings.